HLA haploidentical hematopoietic stem cell transplantation, Phase II trial
Phase 2
Recruiting
- Conditions
- hematologic malignancies, bone marrow failure syndrome, and other hematological disorders which requires hematopoietic stem cell transplantation
- Registration Number
- JPRN-UMIN000027049
- Lead Sponsor
- Hyogo College of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1) allergic for drugs used in this protocol 2) active CNS lesion (exclude original disease) 3) active infection 4) when the physician in chief decides the patient is inappropriate for this protocol
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival at day 100 after transplantation
- Secondary Outcome Measures
Name Time Method